2Lowe J,Li H,Downing KH,et al.Refined structure of α β-tubulin at A resolution[J].J Mol Biol,2001,313(5):1045-1057.
3Tuszynski JA,Carpenter EJ,Huzil JT,et al.The evolution of the structure of tubulin and its potential consequences for the role and function of microtubules in cells and embryos[J].International Journal of Developmental Biology,2006,50(2-3):341-358.
4Houtman SH,Rutteman M,de Zeeuw CI,et al.Echinoderm microtubule-associated protein like protein 4,a member of the echinoderm microtubule-associated protein family,stabilizes microtubules[J].Neuroscience,2007,144(4):1373-1382.
5Haller DG,Misset JI.Docetaxel in advanced gastric cancer[J].Anticancer Drugs,2002,13(5):451-460.
6Sunters A,Madureira PA,Pomeranz KM,et al.Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by Cjun NH2-terminal kinase and Akt[J].Cancer Res,2006,66(1):212-220.
7Mhaidat NM,Wang Y,Kiejda KA,et al.Docetaxel-induced apoptosis in melanoma cells is dependent on activation of caspase-2[J].Molecular Cancer Therapeutics,2007,6(2):752-761.
8von Minckwitz G.Docetaxel/anthracycline combinations for breast cancer treatment[J].Expert Opinion on Pharmacotherapy,2007,8(4):485-495.
9Mozzetti S,Ferlini C,Concolino P,et al.Class Ⅲ beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients[J].Clin Cancer Res,2005,11(1):298-305.
10Manetti F,Forli S,Maccari L,et al.3D QSAR studies of the interaction between β-tubuli and microtubule stabilizing antimitotic agents(MSAA).A combined pharmacophore generation and pseudoreceptor modeling approach to tanxanes and ephothilones[J].IL Farmaco,2003,58(5):357.
